InSightec Stock

InSightec develops and manufactures MR-guided Focused Ultrasound technology devices for image-guided acoustic surgery.

Sign up today and learn more about InSightec Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Koch Disruptive Technologies


Dallas TX, US

Total Funding


About InSightec Stock

InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery. ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.


Koch Disruptive Technologies

Dragos, Desktop Metal, InSightec, fabric, D2iQ, 8fig, Automox, Ibotta

Funding History

November 2007$30.0M
December 2012$30.9M
December 2014$59.0M
January 2016$22.0M
December 2017$150M
March 2020$150M



Roni Karie

CEO & Chairman

Maurice Ferre, M.D.

CEO and Founder

Kobi Vortman


jewishbusinessnews - Oct, 18 2021

Insightec Set for $2 Billion IPO

businessinsider - Dec, 7 2019

This time it actually is brain surgery

fiercemedicaldevices - Sep, 29 2015

How did Israel become a hotbed for medical devices?

fastcompany - May, 21 2015

Brain Surgery Without the Mess

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: